Cargando…
Reviving the use of inhibitors of matrix metalloproteases in spinal cord injury: a case for specificity
At present, there are no restorative therapies in the clinic for spinal cord injury, with current treatments offering only palliative treatment options. The role of matrix metalloproteases is well established in spinal cord injury, however, translation into the clinical space was plagued by early de...
Autor principal: | Ahmed, Zubair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233756/ https://www.ncbi.nlm.nih.gov/pubmed/36926709 http://dx.doi.org/10.4103/1673-5374.367837 |
Ejemplares similares
-
Physiology and pathophysiology of matrix metalloproteases
por: Klein, T., et al.
Publicado: (2010) -
Decorin treatment of spinal cord injury
por: Esmaeili, Maryam, et al.
Publicado: (2014) -
Glycosylation of matrix metalloproteases and tissue inhibitors: present state, challenges and opportunities
por: Boon, Lise, et al.
Publicado: (2016) -
Evaluation of indomethacin as matrix metalloproteases inhibitor in human dentin
por: Shailendra, Mashalkar, et al.
Publicado: (2019) -
Aquaporins and Their Regulation after Spinal Cord Injury
por: Halsey, Andrea M., et al.
Publicado: (2018)